市場調查報告書
商品編碼
1133523
膠原蛋白和明膠的全球市場-2022-2029Global Collagen & Gelatin Market - 2022-2029 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球膠原蛋白和明膠市場慢性病的興起、人口老齡化的迅速擴大以及再生醫學資金的增加是推動全球對再生醫學膠原蛋白和明膠需求的重要因素。因為它正在增長。此外,由於預期壽命延長和肉類產量增加,亞太和南美等新興經濟體為這些地區提供了重要機會,這主要導致慢性病。
慢性病的流行將推動市場增長
膠原蛋白和明膠存在於人體中,尤其是皮膚和骨骼中。一定年齡後,體內膠原蛋白的正常發育會下降。缺乏膠原蛋白會導致慢性疾病,如骨質疏鬆症、骨骼和關節疼痛、慢性傷口、心血管疾病和其他神經退行性疾□□病。由於這些慢性疾病會導致器官和組織的破壞,因此需要開發恢復組織的治療方法。例如,根據美國疾病控制和預防中心 (CDC) 的數據,心血管疾病是全球第一大死因,2020 年估計每年有 697,000 人死亡。
嚴格的規定以及膠原蛋白和明膠替代品的存在
來自牛和豬的膠原蛋白具有傳播疾病的風險,這是對膠原蛋白和明膠需求的主要限制。此外,歐盟(EU)對這些補充劑進行了嚴格的限制,這也是對目標市場的阻礙。此外,在預測期內,越來越多地使用生物材料替代膠原蛋白和明膠也對膠原蛋白和明膠市場的增長構成重大挑戰。
COVID-19 影響分析
COVID-19 正在對全球各個市場產生負面影響。突然的封鎖和航空公司禁令擾亂了供應鍊和製造單位的流動。這些因素對市場份額產生了負面影響。根據最近的研究,膠原蛋白在對抗 COVID-19 等疾病方面發揮著關鍵作用。這些結果有利於藥物和疫苗的開發,目前發揮著重要作用。這些屬性將推動未來的市場增長。
行業分析
全球膠原蛋白和明膠市場根據各種行業因素(包括波特五力、監管分析、供應鏈分析和定價分析)對市場進行了深入分析。
Collagen & Gelatin Market size was valued US$ 5010.6 million in 2021 and is estimated to reach US$ 7019.6 million by 2029, growing at a CAGR of 5.0% during the forecast period (2022-2029).
Collagen peptide is a cold-soluble and easily digested type of collagen. It is the essential building block that makes up about 30% of the human body's protein. Collagen peptide contains higher concentrations of glycine, hydroxyproline, and proline. Likewise, gelatin is primarily composed of two components, such as proline and amino acid glycine. It is derived from animal bones, lungs, and fibrous tissues. Gelatin is essential for proper hair, skin, and nail development, weight control, and optimal immune function.
The global collagen & gelatin market is growing due to the increasing prevalence of chronic diseases, rapid growth in ageing populations, and increased funding for regenerative medicines are essential factors driving the global demand for collagen & gelatin for regenerative medication. Moreover, emerging economies, such as Asia-Pacific and South America, offer significant opportunities in these regions, mainly due to increased life expectancy resulting in chronic diseases and increased meat production.
Rising prevalence of chronic diseases drives the growth of the market
Collagen & gelatin are present in the human body, particularly in the skin and bones. The normal development of collagen in the body declines after a certain age. Lack of collagen causes chronic diseases such as osteoporosis, bone and joint pain, chronic wounds, cardiovascular diseases, and other neurodegenerative disorders. These chronic diseases result in organ and tissue destruction, leading to the creation of treatments that can restore tissues. For instance, according to the centres for disease control and prevention (CDC), in United States, cardiovascular diseases are the leading cause of death globally, accounting for 697,000 people deaths per year in 2020.
Strict regulations and the presence of substitutes for collagen & gelatin
Collagen derived from bovine and porcine sources carries the risk of disease transmission, which is the primary constraint on the demand for collagen & gelatin. Another aspect that hinders the target market is the tight limitations on these supplements by the European Union. Moreover, the increasing use of biomaterials, which alternate to collagen & gelatin, is a significant challenge for the growth of the collagen & gelatin market in the forecast period.
COVID-19 Impact Analysis
COVID-19 has had a negative impact on different markets around the world. Due to sudden locking restrictions and a ban on airlines, there is a split in the movement of supply chain and manufacturing units. These factors negatively disrupted market shares. Collagen has played a significant role in the war against diseases such as COVID-19 in recent studies. These results are beneficial in developing a drug or vaccine that is a critical part of the current situation. These attributes would boost the growth of the market in the future.
Industry Analysis
The global collagen & gelatin market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis and pricing analysis.
The collagen segment is expected to hold the largest market share in global collagen & gelatin market
The collagen segment dominating growth is primarily driven because increasing end-use applications such as growing usage in the food & beverage industry and an upsurge in demand from the cosmetics industry. Although, partial hydrolysis of collagen contributes to the formation of gelatin. The gelatin segment dominates the market due to its high use in the food & beverage, cosmetics, and medical industries. Also, the growing number of chronic disease patients and the increasing number of ageing shares of the entire population in the developing countries are further estimated to lead the growth of the segment worldwide during the forecast period.
North America region holds the largest market share in the global collagen & gelatin market
North America was held a dominant position in the global collagen & gelatin market in 2021. In North America, the US is expected to represent considerable growth during the forecast period. In the US, the collagen & gelatin market is projected to grow exponentially due to the rising prevalence of chronic diseases in the region. Moreover, South America is expected to represent significant growth in terms of value during the forecast period. Availability of government and private funding for R&D is expected to propel market growth across the region. Collagen & Gelatin market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the region's ageing population's development, especially in India and China. Moreover, increasing research on collagen & gelatin-based products is the primary factor creating a lucrative opportunity for the growth of the Asia Pacific collagen & gelatin market in the forecast years.
The collagen & gelatin market is highly competitive, owing to big market players in the industry. The key collagen & gelatin players which are contributing to the growth of the global market include Rousselot, Collagen Solutions Plc, Darling Ingredients Inc., Ewald-Gelatine GmbH, GELITA AG, GELNEX, Holista Colltech Limited, LAPI GROUP SpA, Tessenderlo Group, Trobas Gelatine B.V. among others. The major players are adopting new product development and expansion strategies for global growth in the collagen & gelatin market.
Overview: Rousselot is one the global leader in collagen-based solutions* for the food, health & nutrition, (bio)medical, and pharmaceutical sectors. The company offers Peptan, Peptan IIm, ProTake, Rousselot world-class gelatins, SiMoGel, StabiCaps, Synergy Systems, and X-Pure. It primarily serves nutrition and health, biomedical, food, pharmaceuticals, and technical market companies. Rousselot was founded in France in 1891 by Edouard Rousselot.
X-Pure gelatins offer premium-grade solutions, with tunable functionalities and low endotoxins ≤ 10 EU/g, and are one of the most favorable biomaterials for tissue or stem cell bioengineering. X-Pure products are customizable and include X-Pure Gelatin, X-Pure GelMA, and X-Pure GelDAT.
The global collagen & gelatin market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.